Indication

Meibomianitis

Meibomianitis, also termed meibomitis, is an inflammatory disorder affecting the meibomian glands, which are specialized sebaceous glands situated within the tarsal plates of the eyelids. Read more about Meibomianitis

48 drugs 27 manufacturers

Advertisement

Drugs that treat it

Common Meibomianitis therapies.

Showing 46–48 of 48 drugs

TOBRAMYCIN

OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
REMEDYREPACK, I
Filter & compare in the drug finder →Opens the drug finder with Meibomianitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Meibomianitis.

Meibomianitis, also termed meibomitis, is an inflammatory disorder affecting the meibomian glands, which are specialized sebaceous glands situated within the tarsal plates of the eyelids.

Typically categorized under posterior blepharitis or inflammatory meibomian gland dysfunction, it commonly affects adults and frequently co-occurs with systemic dermatologic conditions like rosacea or seborrheic dermatitis.

Pathophysiologically, the condition is characterized by terminal duct hyperkeratinization, ductal obstruction, altered lipid (meibum) composition, and bacterial overgrowth.

Clinically, this leads to eyelid margin vascular engorgement, plugged glandular orifices, ocular irritation, and secondary tear film instability, frequently resulting in evaporative dry eye disease.

Personalize your experience

Follow Meibomianitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it